시장보고서
상품코드
1429621

세계의 연구용 항체 및 시약 시장 보고서(2024년)

Research Antibodies and Reagents Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

연구용 항체 및 시약 시장 규모는 향후 몇 년 동안 큰 폭으로 성장할 것으로 예상됩니다. 2028년까지 10.0%의 연평균 복합 성장률(CAGR)로 240억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 노인 인구 증가, 암 및 만성질환 유병률 증가, R&D 지출 증가, 헬스케어 지출 급증, 프로테오믹스 벤처에 대한 자금 조달 증가, 프로테오믹스 수요 증가 등의 요인에 기인하는 것으로 보입니다. 개인 맞춤형 의료, 감염성 질환의 출현. 예측 기간 동안 예상되는 주요 동향으로는 저농도 분자의 식별을 위한 나노기술 도입에 대한 집중, 매출 및 수익성 향상을 위한 혁신적인 기술 제품 도입, 첨단 항체 정제 기술 활용에 대한 강조, 인수 및 다른 연구와의 합병 검토, 정부 기관, 센터, 연구 개발 연구소 및 연구소에 대한 투자 등을 들 수 있습니다.

연구용 항체 및 시약 시장의 예상 확대는 의료 및 건강 연구 및 개발(R&D)에 대한 투자 증가에 기인합니다. 생명과학 연구 분야에서 항체와 시약은 면밀한 실험, 관찰, 실험실 작업, 분석 및 테스트를 통해 생물학적 과정을 탐색하고 질병의 원인을 조사하는 데 필수적인 역할을 합니다. 일례로 2021년 4월 미국 의회예산국(CBO)이 발표한 보고서에 따르면 전 세계 제약회사들이 연구개발 활동에 830억 달러를 투자할 것으로 예상됩니다. 그 결과, 헬스케어 R&D에 대한 투자가 증가하면서 연구용 항체 및 시약 시장의 이용이 확대되는 추세입니다.

연구용 항체 및 시약 시장의 성장은 개인 맞춤형 의료에 대한 수요 증가로 인해 더욱 촉진되고 있습니다. 개인 맞춤형 의료는 개인의 고유한 유전적 구조에 맞게 의료를 조정하여 보다 효과적이고 정확한 의료 개입을 제공합니다. 연구용 항체 및 시약은 정밀의료 접근법을 형성하는 데 있어 매우 중요한 역할을 하며, 개별 환자 프로필에 기반한 맞춤형 진단 및 치료를 촉진하는 데 있어 중요한 역할을 합니다. 치료용 NME의 약 34%(35개 중 12개)가 개인맞춤의료연합(PMC)에 의해 개인맞춤형 의약품으로 분류되었습니다. 따라서 맞춤의료에 대한 수요가 급증하면서 연구용 항체 및 시약 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • COVID-19에 의한 시장에 대한 영향

제5장 세계 시장 규모와 성장

  • 세계의 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 규모 실적과 성장, 2018-2023년
  • 세계의 시장 규모 예측과 성장, 2023-2028년, 2033년

제6장 시장 세분화

  • 세계의 연구용 항체 및 시약 시장, 기술별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 웨스턴 블롯
  • 면역형광
  • 면역조직화학
  • 유세포 분석
  • 효소결합면역흡착 검정법(ELISA)
  • 멀티플렉스 면역흡착 어세이
  • 면역침강
  • 기타 기술
  • 세계의 연구용 항체 및 시약 시장, 용도별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 프로테오믹스
  • Drug Discovery & Development
  • 게노믹스
  • 세계의 연구용 항체 및 시약 시장, 최종사용자별 세분화, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 제약 및 바이오테크놀러지 산업
  • 학술연구기관
  • 수탁연구기관(CRO)

제7장 지역 및 국가 분석

  • 세계의 연구용 항체 및 시약 시장, 지역별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 연구용 항체 및 시약 시장, 국가별, 실적 및 예측, 2018-2023년, 2023-2028년, 2033년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 상황과 기업 개요

  • 연구용 항체 및 시약 시장 경쟁 상황
  • 연구용 항체 및 시약 시장 기업 개요
    • Thermo Fisher Scientific Inc.
    • Abcam plc
    • Cell Signaling Technology, Inc.
    • Merck KGaA
    • Santa Cruz Biotechnology, Inc.

제31장 기타 주요 및 혁신적인 기업

  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Johnson &Johnson
  • F. Hoffmann-La Roche AG
  • Becton Dickinson and Company
  • Biocon
  • Immunochina
  • Takara Bio
  • GE Healthcare
  • Zhejiang Kangte Biotechnology Co., Ltd.
  • Wuxi Tech-star Technology Co., Ltd.
  • Shaanxi Bloom Tech Co., Ltd.
  • PerkinElmer Inc.
  • Lonza Group AG
  • GenScript Biotech Corporation

제32장 경쟁 벤치마킹

제33장 경쟁 대시보드

제34장 주요 인수합병

제35장 향후 전망과 가능성 분석

제36장 부록

ksm 24.03.21

Research antibodies and reagents are essential tools used by bio scientists as fundamental detection techniques. These antibodies play a crucial role in identifying and distinguishing specific proteins present within a diseased cell at a particular stage of its life cycle.

The primary technologies employed in research antibodies and reagents include western blot, immunofluorescence, immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA), multiplex immunosorbent assay, immunoprecipitation, and others. Western blot, also known as western blotting, is an analytical technique in molecular biology and immunogenetics used to detect specific proteins in a sample of tissue homogenate or extract. These technologies find applications in various fields such as proteomics, drug discovery and development, and genomics. Additionally, they are widely utilized across sectors including the pharmaceutical and biotechnology industry, academic and research institutes, and contract research organizations (CROs).

The research antibodies and reagents market research report is one of a series of new reports from The Business Research Company that provides research antibodies and reagents market statistics, including research antibodies and reagents industry global market size, regional shares, competitors with a research antibodies and reagents market share, detailed research antibodies and reagents market segments, market trends and opportunities, and any further data you may need to thrive in the research antibodies and reagents industry. This research antibodies and reagents market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The research antibodies and reagents market size has grown strongly in recent years. It will grow from $15.19 billion in 2023 to $16.44 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth observed in the historical period can be attributed to the rise in pharmaceutical research and development (R&D) expenditure, an increase in the geriatric population, heightened healthcare expenditure, augmented government funds allocated for research, and a growth in the number of healthcare facilities.

The research antibodies and reagents market size is expected to see strong growth in the next few years. It will grow to $24.04 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period can be ascribed to factors such as the growing geriatric population, heightened prevalence of cancer and chronic diseases, increased spending on research and development, a surge in healthcare expenditure, augmented financing for proteomics ventures, a rising demand for personalized medicine, and the emergence of infectious diseases. Key trends expected in the forecast period include a focus on incorporating nanotechnology for the identification of low-abundant molecules, the introduction of innovative technological products to enhance sales and profitability, emphasis on utilizing advanced antibody purification technologies, consideration of acquisitions and mergers with other research agencies and centers, and investments in research and development labs and initiatives.

The expected expansion in the research antibodies and reagents market can be attributed to the increasing investment in medical and health research and development (R&D). In the realm of life science research, antibodies and reagents play indispensable roles in the exploration of biological processes or the investigation of causes of diseases through meticulous experimentation, observation, laboratory work, analysis, and testing. As an illustration, a report published by the Congressional Budget Office in April 2021 indicated that pharmaceutical companies globally were projected to invest $83 billion in research and development activities. Consequently, the heightened investment in healthcare research and development is poised to amplify the utilization of the research antibodies and reagents market.

The growth of the research antibodies and reagents market is further driven by the increasing demand for personalized medicine. Personalized medicine tailors medical treatment to an individual's unique genetic makeup, providing more effective and precise healthcare interventions. Research antibodies and reagents play a pivotal role in shaping precision medicine approaches, facilitating targeted diagnostics and therapies based on individual patient profiles. As evidenced in 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% of the therapeutic NMEs (12 out of 35) classified as personalized medicines by the Personalized Medicine Coalition (PMC). Hence, the surge in demand for personalized medicine propels the growth of the research antibodies and reagents market.

The research antibodies and reagents market present growth opportunities during the forecast period, driven by technological advancements in the purification of antibodies and reagents. A significant challenge faced by the industry is the issue of irreproducible antibodies and reagents, which can impact research outcomes. In April 2021, the UK-based Native Antigen Company addressed this challenge by launching the SARS-CoV-2 Neutralization Assay Development Kit. This kit includes essential reagents for measuring Spike-antibody binding, focusing on the RBD-ACE2 interaction to identify and qualitatively measure neutralizing antibodies.

Major players in the research antibodies and reagents market are concentrating on developing reagent solutions for immunohistochemistry to gain a competitive advantage. These reagent solutions typically comprise antibodies and blocking agents in a buffered solution. For example, in March 2023, the UK-based Aptamer Group PLC introduced Optimer-Fc, designed for use in automated immunohistochemistry workflows. Optimer-Fc is an innovative solution combining an Optimer binder with the Fc domain of an antibody, serving as a viable substitute for primary detecting antibodies in various IHC applications. This approach allows seamless integration into existing workflows, replacing the primary detecting antibody without compromising the process's integrity.

In February 2022, the US-based Rockland Immunochemicals, Inc., acquired Germany-based Antibodies-Online GmbH, marking a strategic move to enhance capabilities in designing, developing, and manufacturing antibodies and assays. This acquisition leverages Antibodies-Online's e-commerce brand, supplier network, and technology stack, providing customers with improved capabilities supported by comprehensive data sets, enhancing the overall customer experience and strengthening their market strategy.

Major companies operating in the research antibodies and reagents market report are Thermo Fisher Scientific Inc., Abcam PLC, Cell Signaling Technology, Inc., Merck KGaA, Santa Cruz Biotechnology, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Biocon, Immunochina, Takara Bio, GE Healthcare, Zhejiang Kangte Biotechnology Co., Ltd., Wuxi Tech-star Technology Co., Ltd., Shaanxi Bloom Tech Co., Ltd., PerkinElmer Inc., Lonza Group AG, GenScript Biotech Corporation, Bio-Techne Corporation.

North America was the largest region in the research antibodies and reagents market in 2023. The regions covered in the research antibodies and reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the research antibodies and reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The research antibodies and reagents market consists of sales of buffers, fixatives, solvents, and enzymes. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Research Antibodies and Reagents Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on research antibodies and reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for research antibodies and reagents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The research antibodies and reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Technology: Western Blot; Immunofluorescence; Immunohistochemistry; Flow Cytometry; Enzyme-Linked Immunosorbent Assay (Elisa); Others
  • 2) By Application: Proteomics, Genomics; Other Applications
  • 3) By End User: Pharmaceutical & Biotechnology Industry; Academic & Research Institutes; Contract Research Organizations (CROs)
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Abcam plc; Cell Signaling Technology, Inc.; Merck KGaA; Santa Cruz Biotechnology, Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Research Antibodies and Reagents Market Characteristics

3. Research Antibodies and Reagents Market Trends And Strategies

4. Research Antibodies and Reagents Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Research Antibodies and Reagents Market Size and Growth

  • 5.1. Global Research Antibodies and Reagents Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Research Antibodies and Reagents Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Research Antibodies and Reagents Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Research Antibodies and Reagents Market Segmentation

  • 6.1. Global Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Western Blot
  • Immunofluorescence
  • Immunohistochemistry
  • Flow Cytometry
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Multiplex Immunosorbent Assay
  • Immunoprecipitation
  • Other Technologies
  • 6.2. Global Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Proteomics
  • Drug Discovery & Development
  • Genomics
  • 6.3. Global Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical & Biotechnology Industry
  • Academic & Research Institutes
  • Contract Research Organizations (CROs)

7. Research Antibodies and Reagents Market Regional And Country Analysis

  • 7.1. Global Research Antibodies and Reagents Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Research Antibodies and Reagents Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Research Antibodies and Reagents Market

  • 8.1. Asia-Pacific Research Antibodies and Reagents Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Research Antibodies and Reagents Market

  • 9.1. China Research Antibodies and Reagents Market Overview
  • 9.2. China Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Research Antibodies and Reagents Market

  • 10.1. India Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Research Antibodies and Reagents Market

  • 11.1. Japan Research Antibodies and Reagents Market Overview
  • 11.2. Japan Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Research Antibodies and Reagents Market

  • 12.1. Australia Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Research Antibodies and Reagents Market

  • 13.1. Indonesia Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Research Antibodies and Reagents Market

  • 14.1. South Korea Research Antibodies and Reagents Market Overview
  • 14.2. South Korea Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Research Antibodies and Reagents Market

  • 15.1. Western Europe Research Antibodies and Reagents Market Overview
  • 15.2. Western Europe Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Research Antibodies and Reagents Market

  • 16.1. UK Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Research Antibodies and Reagents Market

  • 17.1. Germany Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Research Antibodies and Reagents Market

  • 18.1. France Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Research Antibodies and Reagents Market

  • 19.1. Italy Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Research Antibodies and Reagents Market

  • 20.1. Spain Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Research Antibodies and Reagents Market

  • 21.1. Eastern Europe Research Antibodies and Reagents Market Overview
  • 21.2. Eastern Europe Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Research Antibodies and Reagents Market

  • 22.1. Russia Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Research Antibodies and Reagents Market

  • 23.1. North America Research Antibodies and Reagents Market Overview
  • 23.2. North America Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Research Antibodies and Reagents Market

  • 24.1. USA Research Antibodies and Reagents Market Overview
  • 24.2. USA Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Research Antibodies and Reagents Market

  • 25.1. Canada Research Antibodies and Reagents Market Overview
  • 25.2. Canada Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Research Antibodies and Reagents Market

  • 26.1. South America Research Antibodies and Reagents Market Overview
  • 26.2. South America Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Research Antibodies and Reagents Market

  • 27.1. Brazil Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Research Antibodies and Reagents Market

  • 28.1. Middle East Research Antibodies and Reagents Market Overview
  • 28.2. Middle East Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Research Antibodies and Reagents Market

  • 29.1. Africa Research Antibodies and Reagents Market Overview
  • 29.2. Africa Research Antibodies and Reagents Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Research Antibodies and Reagents Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Research Antibodies and Reagents Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Research Antibodies and Reagents Market Competitive Landscape And Company Profiles

  • 30.1. Research Antibodies and Reagents Market Competitive Landscape
  • 30.2. Research Antibodies and Reagents Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abcam plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cell Signaling Technology, Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck KGaA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Santa Cruz Biotechnology, Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Research Antibodies and Reagents Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories, Inc.
  • 31.2. Danaher Corporation
  • 31.3. Johnson & Johnson
  • 31.4. F. Hoffmann-La Roche AG
  • 31.5. Becton Dickinson and Company
  • 31.6. Biocon
  • 31.7. Immunochina
  • 31.8. Takara Bio
  • 31.9. GE Healthcare
  • 31.10. Zhejiang Kangte Biotechnology Co., Ltd.
  • 31.11. Wuxi Tech-star Technology Co., Ltd.
  • 31.12. Shaanxi Bloom Tech Co., Ltd.
  • 31.13. PerkinElmer Inc.
  • 31.14. Lonza Group AG
  • 31.15. GenScript Biotech Corporation

32. Global Research Antibodies and Reagents Market Competitive Benchmarking

33. Global Research Antibodies and Reagents Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Research Antibodies and Reagents Market

35. Research Antibodies and Reagents Market Future Outlook and Potential Analysis

  • 35.1 Research Antibodies and Reagents Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Research Antibodies and Reagents Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Research Antibodies and Reagents Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제